| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 7.37e-05 | 357 | 26 | 5 | GO:0009101 | |
| Domain | Sulfotransferase_dom | 9.71e-04 | 36 | 24 | 2 | IPR000863 | |
| Domain | Sulfotransfer_1 | 9.71e-04 | 36 | 24 | 2 | PF00685 | |
| Domain | FERM_M | 1.58e-03 | 46 | 24 | 2 | PF00373 | |
| Domain | FERM_domain | 1.79e-03 | 49 | 24 | 2 | IPR000299 | |
| Domain | FERM_central | 1.79e-03 | 49 | 24 | 2 | IPR019748 | |
| Domain | - | 1.79e-03 | 49 | 24 | 2 | 1.20.80.10 | |
| Domain | FERM_1 | 1.87e-03 | 50 | 24 | 2 | PS00660 | |
| Domain | FERM_2 | 1.87e-03 | 50 | 24 | 2 | PS00661 | |
| Domain | B41 | 1.87e-03 | 50 | 24 | 2 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.87e-03 | 50 | 24 | 2 | IPR014352 | |
| Domain | FERM_3 | 1.87e-03 | 50 | 24 | 2 | PS50057 | |
| Domain | Band_41_domain | 1.87e-03 | 50 | 24 | 2 | IPR019749 | |
| Domain | Ig_sub2 | 3.27e-03 | 235 | 24 | 3 | IPR003598 | |
| Domain | IGc2 | 3.27e-03 | 235 | 24 | 3 | SM00408 | |
| Domain | - | 1.42e-02 | 746 | 24 | 4 | 3.40.50.300 | |
| Domain | Ig_sub | 1.62e-02 | 421 | 24 | 3 | IPR003599 | |
| Domain | IG | 1.62e-02 | 421 | 24 | 3 | SM00409 | |
| Domain | P-loop_NTPase | 2.17e-02 | 848 | 24 | 4 | IPR027417 | |
| Domain | Ubiquitin-rel_dom | 2.31e-02 | 184 | 24 | 2 | IPR029071 | |
| Domain | IG_LIKE | 2.43e-02 | 491 | 24 | 3 | PS50835 | |
| Domain | Immunoglobulin | 2.45e-02 | 190 | 24 | 2 | IPR013151 | |
| Domain | I-set | 2.45e-02 | 190 | 24 | 2 | PF07679 | |
| Domain | Ig_I-set | 2.45e-02 | 190 | 24 | 2 | IPR013098 | |
| Domain | ig | 2.45e-02 | 190 | 24 | 2 | PF00047 | |
| Domain | Ig-like_dom | 2.58e-02 | 503 | 24 | 3 | IPR007110 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 4.03e-04 | 123 | 17 | 3 | MM14623 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 4.20e-04 | 307 | 17 | 4 | M894 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 4.33e-04 | 126 | 17 | 3 | M695 | |
| Pathway | KEGG_N_GLYCAN_BIOSYNTHESIS | 1.37e-03 | 46 | 17 | 2 | M11079 | |
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | 2.32e-04 | 410 | 26 | 4 | 25814554 | |
| Pubmed | Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study. | 2.63e-04 | 32 | 26 | 2 | 25189868 | |
| Pubmed | Association of gene polymorphisms with chronic kidney disease in Japanese individuals. | 3.91e-04 | 39 | 26 | 2 | 19724895 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 9.93e-04 | 50 | 17 | 2 | 1293 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 9.82e-03 | 161 | 17 | 2 | 593 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-06 | 172 | 26 | 4 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-06 | 199 | 26 | 4 | 1bb02f41f3cc76a28581e38b0ca4c36b930b85b4 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-06 | 199 | 26 | 4 | 2f60682f1b82918a65e8851e99c9e3398845b62f | |
| ToppCell | PBMC-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 6.25e-05 | 133 | 26 | 3 | e53fbd69775a4bff61de82557342f7ac80915c4d | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.84e-05 | 155 | 26 | 3 | 0fd66c623cb433ceaa893bc21ba2e3b394faaf70 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.00e-04 | 156 | 26 | 3 | da5cfa8fa9595613f04ce9511f8b42bad34d995a | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-7|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.06e-04 | 159 | 26 | 3 | 75a82bbabd97b168dbf1c3f43a9bdad48ce18c78 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.08e-04 | 160 | 26 | 3 | bb1bb3673059768c0ea0160d29fff127f3a4ecb4 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-04 | 160 | 26 | 3 | 76f49b8b4450fa8acd36326bfa36a5d1f4bd95fb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 162 | 26 | 3 | 8278dccdb139396ede34b83b02ebce837f2489d6 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 166 | 26 | 3 | 2e4cb4056e6b0c43290a5588ff525f5f05b8beee | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 166 | 26 | 3 | eb8d972326a734549675307e411fc795af66da70 | |
| ToppCell | mild-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.23e-04 | 167 | 26 | 3 | 0811f7559c2a7151693771e52e14af3978997118 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 1.23e-04 | 167 | 26 | 3 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.25e-04 | 168 | 26 | 3 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 1.25e-04 | 168 | 26 | 3 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.29e-04 | 170 | 26 | 3 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-04 | 170 | 26 | 3 | 4b1c84b35b7242a297ffdb9c23a6d982acf1bed5 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-04 | 171 | 26 | 3 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.32e-04 | 171 | 26 | 3 | 1af575809b3334bfaa019ff26c56e6cb03c82ee8 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 1.32e-04 | 171 | 26 | 3 | fcc31a9a69f96de10d1324a5a4fbfe4289bf4984 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 172 | 26 | 3 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.34e-04 | 172 | 26 | 3 | 1215f61f115b042f84721b64c2ed1f48081535f1 | |
| ToppCell | Healthy-Plasmablast|World / disease group, cell group and cell class | 1.38e-04 | 174 | 26 | 3 | 6becb456d8f44a1224c6d42be78d4c8cdb51f199 | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 1.43e-04 | 176 | 26 | 3 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.46e-04 | 177 | 26 | 3 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-04 | 178 | 26 | 3 | 812e261d9cbdc74fafe3c5c3422151c1cfacb22d | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.48e-04 | 178 | 26 | 3 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 180 | 26 | 3 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | ICU-NoSEP-Myeloid-tDC|ICU-NoSEP / Disease, Lineage and Cell Type | 1.53e-04 | 180 | 26 | 3 | be665e801512f6aaf6b3ecb26153bbdeb24619ac | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 180 | 26 | 3 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 181 | 26 | 3 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.56e-04 | 181 | 26 | 3 | ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 183 | 26 | 3 | 377c2c6fcb2fd41396dd7a7a90e9d7ccafccf2f0 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.61e-04 | 183 | 26 | 3 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 183 | 26 | 3 | f0a6f4f8563491c83fb991b9fb81e75fec7d1ace | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-SELL+_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 184 | 26 | 3 | d5b8604142ae70abbfa4ea881ce55b2a3a2a46a6 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 1.69e-04 | 186 | 26 | 3 | 5624b1fc7eab9f505588fcc86a24d14f8bcbfef7 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 1.69e-04 | 186 | 26 | 3 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-Naive_B_cells|Liver / Manually curated celltypes from each tissue | 1.69e-04 | 186 | 26 | 3 | 23efdcedbe67f5e6c59106e052f570cd0338f1c1 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 186 | 26 | 3 | fddc6b93f98b10aaf8d4ebc142b46d8213f3129d | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 1.71e-04 | 187 | 26 | 3 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.74e-04 | 188 | 26 | 3 | e5ab89030783461e9367ab87c353fb5c31911020 | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.74e-04 | 188 | 26 | 3 | 13653481d64c7a1ad833d738a3ee0bb9def7cec7 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.74e-04 | 188 | 26 | 3 | ef05d2fb17fd427d46d454e67073e0e1b45bb24c | |
| ToppCell | 356C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 189 | 26 | 3 | d1bd3b5ac32459929e556fb3a4fe8e1e15f6e658 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-04 | 189 | 26 | 3 | b0244a9d1b5c8ad4708750b691184f3491b13900 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.77e-04 | 189 | 26 | 3 | ebaf722738c71d5f33f72341f801c6880f4aee14 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Immature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.77e-04 | 189 | 26 | 3 | 5776f842b3047d21ccdc44db884bfd210823c7da | |
| ToppCell | 10x5'-Liver-Lymphocytic_B|Liver / Manually curated celltypes from each tissue | 1.77e-04 | 189 | 26 | 3 | 1ebff8185060d78f27f8d887e9adaa5f8faf2196 | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 189 | 26 | 3 | 0994aba7a44577a8943af237c9c3575502d0584c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue | 1.79e-04 | 190 | 26 | 3 | 3d45d5011305f13634013d9eeb98f235517dd54e | |
| ToppCell | wk_08-11-Epithelial-PNS-Early_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.79e-04 | 190 | 26 | 3 | 8190674a48607984726974765aafbca116f437e0 | |
| ToppCell | Control-Myeloid-tDC|Control / Disease, Lineage and Cell Type | 1.82e-04 | 191 | 26 | 3 | 5c1d6a52181eba01e9177d00fe941dda85ef7eb2 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Late_pre-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 191 | 26 | 3 | 2b05be1888cccd03a32341bcb1de4a899d4179fd | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 1.82e-04 | 191 | 26 | 3 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.85e-04 | 192 | 26 | 3 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.85e-04 | 192 | 26 | 3 | 5d6569b0f879729aa89d4498c9c886ac9050be13 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B|bone_marrow / Manually curated celltypes from each tissue | 1.85e-04 | 192 | 26 | 3 | 8a284b6e499f5a3c116d5551430f00ecad4a3681 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.88e-04 | 193 | 26 | 3 | efa91167dc7a59bf32addf90ffb7bf070b2a0151 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-04 | 194 | 26 | 3 | e9c907b8ec4329946338cca5ce8e954fa2cec37b | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-naive_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-04 | 194 | 26 | 3 | 4a4cc61193344bb151439f63d0584abddde47cf0 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Immature_B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.91e-04 | 194 | 26 | 3 | f957cec2f309d726e095d18a7da32789dca92a36 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-04 | 195 | 26 | 3 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B|bone_marrow / Manually curated celltypes from each tissue | 1.94e-04 | 195 | 26 | 3 | bcbf0305ca9337a6f3021178dbb47a7fbf1030a4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.00e-04 | 197 | 26 | 3 | 06ed8f293d4ee89f14dc2f43d6cae93bbc02508a | |
| ToppCell | Biopsy_Control_(H.)-Immune-B_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.00e-04 | 197 | 26 | 3 | c78e0cf394b9a4e10ebba61f6392d9b5a23db9d8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B|lymph-node_spleen / Manually curated celltypes from each tissue | 2.00e-04 | 197 | 26 | 3 | 9837bd2cc28b79147fb5d1997631ef953fd020e4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.00e-04 | 197 | 26 | 3 | c115d0a45545ed24259ad88872231bf4d4d389d2 | |
| ToppCell | mild-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.00e-04 | 197 | 26 | 3 | 21085d5e27b5a23a241a933058bb89f8a1fcf198 | |
| ToppCell | severe-Plasmablast|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.03e-04 | 198 | 26 | 3 | 0b1620ad4352ee5d599a72931aaceab4ca407498 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B|lymph-node_spleen / Manually curated celltypes from each tissue | 2.03e-04 | 198 | 26 | 3 | 1780fa1725a321041094e8c4430673c0a4f3d407 | |
| ToppCell | severe-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.06e-04 | 199 | 26 | 3 | 6ee4c2e6049860071169366b7e662d5c1a3cc54b | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-B_intermediate|ICU-NoSEP / Disease, condition lineage and cell class | 2.06e-04 | 199 | 26 | 3 | 97a32b664c89e865cf29f83add794d277fa020cd | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-04 | 199 | 26 | 3 | 58242d78517c05fa367a7c6edac57ef79107453c | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD8+_T_naive|COVID-19_Mild / Disease, condition lineage and cell class | 2.09e-04 | 200 | 26 | 3 | 7192138e2704c030d70561bcd59259fb3ad82f06 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.09e-04 | 200 | 26 | 3 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.09e-04 | 200 | 26 | 3 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | mild-CD8+_T_naive|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.09e-04 | 200 | 26 | 3 | c2513047ef110a64c89a624e299cb9600a9cb92c | |
| ToppCell | Dendritic_Cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.11e-03 | 85 | 26 | 2 | d2776a2c8d1721dbbd7d5dc868a3810e30dd9064 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.63e-03 | 103 | 26 | 2 | d8965b338b90ddc0686ea0d94e9a330128566c39 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|RV / Chamber and Cluster_Paper | 1.69e-03 | 105 | 26 | 2 | 49e16b11f16e83a7d17d162c14bce991201bcc2a | |
| ToppCell | RA-04._Ventricular_Cardiomyocyte_I|RA / Chamber and Cluster_Paper | 1.85e-03 | 110 | 26 | 2 | af7095c6e1501a4440be39b5c16d4872dd6d66e5 | |
| ToppCell | RA-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.02e-03 | 115 | 26 | 2 | 0a37816898eaa18ae49d4d936e1a760f089e0ceb | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.13e-03 | 118 | 26 | 2 | 3b077ad5c68c01b3fcc93f203cb130bb90705af9 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.13e-03 | 118 | 26 | 2 | 08bdf7bc3c9dcbc0f690658fe14e6cc4b9581698 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 2.20e-03 | 120 | 26 | 2 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Nptx2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.27e-03 | 122 | 26 | 2 | 91e338db581b36baffecc323b1909f2069b27242 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.27e-03 | 122 | 26 | 2 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-03 | 125 | 26 | 2 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.53e-03 | 129 | 26 | 2 | 58790c6eaa597b8e8209a0fbc970e9cffa10bca5 | |
| ToppCell | mild_COVID-19-B_cell|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.65e-03 | 132 | 26 | 2 | 4b372483bc106aecc7b96a09131e1695e54e7dc4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Aqp5_Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.81e-03 | 136 | 26 | 2 | 8f5682422ba0b477c1e0700212948457f106cb10 | |
| ToppCell | Mild/Remission-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.81e-03 | 136 | 26 | 2 | 1b3c6edcbe0eb674d2d9c838e83ebe2b93e3eec1 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-03 | 137 | 26 | 2 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-03 | 137 | 26 | 2 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.93e-03 | 139 | 26 | 2 | 7e2c10830c3d16109cab3ed0d64b3532481e497d | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.02e-03 | 141 | 26 | 2 | 1baa054c2ae3b446d1954244b7fbf8af824ef345 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.02e-03 | 141 | 26 | 2 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.06e-03 | 142 | 26 | 2 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f | |
| Disease | response to methotrexate, serum alanine aminotransferase measurement | 6.09e-04 | 43 | 25 | 2 | EFO_0004735, GO_0031427 | |
| Disease | growth-regulated alpha protein measurement | 9.96e-04 | 55 | 25 | 2 | EFO_0008146 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.84e-03 | 75 | 25 | 2 | DOID:1059 (implicated_via_orthology) | |
| Disease | Back pain | 2.47e-03 | 87 | 25 | 2 | HP_0003418 | |
| Disease | anxiety measurement | 3.77e-03 | 108 | 25 | 2 | EFO_0009863 | |
| Disease | ascending aortic diameter | 6.24e-03 | 140 | 25 | 2 | EFO_0021787 | |
| Disease | attempted suicide | 9.91e-03 | 178 | 25 | 2 | EFO_0004321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VRDVRRRYPHYPSDL | 686 | P48751 | |
| HPILRRQRLRYGVYV | 166 | O60909 | |
| TRRHYERLVLPYVRH | 131 | Q03989 | |
| RYRERDVLARTYPHP | 381 | C9J069 | |
| VIERHAHSPERRRRY | 1171 | Q5VU97 | |
| LRGLSYIHQRYILHR | 241 | O94921 | |
| ERAITFRRPSRVHYY | 191 | Q8N123 | |
| SLCFIHRYYRRSPHR | 446 | Q96AA3 | |
| HRYYRRSPHRPLAGL | 451 | Q96AA3 | |
| RLRLIRHYVEAVYPV | 776 | Q5T5X7 | |
| LLIVRERSLHRAPYY | 41 | Q9NS67 | |
| RTLYRFYHEGVPLRH | 316 | Q96RD9 | |
| YRTPVLRRHRYSIFR | 1026 | Q6WRI0 | |
| YIPLRHYYHRHTRSI | 321 | Q15392 | |
| RRHMRVHTRYRPYKC | 331 | Q5JT82 | |
| IRIRHSHSPRSYRQY | 586 | Q9HCS5 | |
| RALRRHLVYYPSARP | 986 | Q8IZU8 | |
| AYLNYHVPRTRREIL | 6 | Q06210 | |
| YHVTYIPDLASRRLR | 126 | Q7Z3Z4 | |
| RVDRLRHHLLPMYSY | 46 | Q86T20 | |
| LREQTHTRHYELYRR | 286 | Q14141 | |
| PIRHYLVRYRALSSE | 641 | P13591 | |
| VRFHRPYRLLMHRYH | 586 | Q6ZN55 | |
| STEEYPHLRPARYRR | 456 | P52849 | |
| VRDSQRVLYIRYRHH | 46 | Q96Q05 | |
| RVLYIRYRHHYPPEN | 51 | Q96Q05 | |
| LIHRGYYVRARAVRH | 51 | O60294 | |
| SHTHIRRPLRYPLLY | 986 | Q6PIF6 |